Back to top
more

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(NASDAQ Mutual Funds) As of Aug 20, 2026 05:21 PM ET

$30.59 USD

-1.13 (-3.56%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

1-Strong Buy of 5 1        

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jul 31, 2026

Total Return %* Percentile Rank Objective
YTD 16.49 13
3 months 13.64 16
6 months 14.79 14
1 Year 53.49 15
3 Year 21.66 9
5 Year 7.81 22
10 Year 10.60 25

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Buy 1
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 45.60
% Yield 1.50
% SEC Yield NA
Net Assets (Mil $) 7/31/2026 5,795.60
% Turnover 7/31/2026 45.00

Risk

3 Year 5 Year 10 Year
Beta 0.73 0.58 0.81
Alpha 6.77 0.10 -0.33
R Squared 0.19 0.19 0.31
Std. Dev. 20.66 20.52 22.00
Sharpe 0.85 0.27 3.00

Sector / Country Weightings

As of 7/31/2026 % of Portfolio
Health 71.18
Other 15.20
Services 11.63
Industrial Cyclical 1.27
Non-Durable 0.68
Finance 0.04

Portfolio Holdings

Top Equity Holdings
(As of 5/31/2026)
% of Portfolio Value (Mil$)
KRYSTAL BIOTECH INC 10.58 557.06
ABBVIE INC 9.22 485.56
AMGEN INC 6.53 343.86
GILEAD SCIENCES INC 4.75 250.21
TOTAL*MONEY MARKET 3.55 186.98
ALNYLAM PHARMACEUTICALS I 2.94 154.52
PRAXIS PRECISION MEDICINE 2.47 129.99
INSMED INC 2.25 118.58
ARGENX SE ADR 2.25 118.25

Stock Holding % of Net Assets

As Of 5/31/2026
Total Issues 189
Avg. P/E 36.51
Avg. P/Book 4.46
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 71,468

Composition

% of Portfolio
Stocks 98.97
Foreign Stocks 11.59
Cash 3.55
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.92
Other -3.44
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 7.55
Small Value 0.00
Foreign Stock 8.94
Emerging Market 0.00
Precious Metal 0.52
Intermediate Bond 17.69
Foreign Bond 7.09
High Yield Bond 0.00